
Keywords: 2-AG; 2-arachidonoyl-glycerol; AEA; anandamide; CB1; cannabinoid receptor type 1; CB2; cannabinoid receptor type 2; CNS; central nervous system; DOPAC; 3,4-Dihydroxyphenylacetic acid; DA; dopamine; D2; dopamine receptor subtype 2; ECS; endocannabinoid sys